Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

NCT ID: NCT01057615

Last Updated: 2011-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to extend previous findings that nutritional supplementation or dietary modification can ameliorate exercise-induced bronchoconstriction. It has been shown in separate studies that fish oil and ascorbic acid (vitamin C) individually protect against EIB by improving pulmonary function and reducing airway inflammation. The main aim of this study is to determine the comparative and additive effects of fish oil and ascorbic acid supplementation on EIB and airway inflammation in asthmatic individuals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asthma Exercise-Induced Bronchoconstriction Inflammation Airway Fish Oil Ascorbic Acid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Fish Oil + Vitamin C Placebo

Fifteen subjects will take 10 active fish oil capsules per day and 2 vitamin C placebo capsules per day for 3 weeks.

Group Type EXPERIMENTAL

Fish Oil

Intervention Type DIETARY_SUPPLEMENT

10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks

Ascorbic Acid Placebo

Intervention Type DIETARY_SUPPLEMENT

2 placebo ascorbic acid (sucrose) capsules per day for 3 weeks

Fish Oil Placebo + Active Vitamin C

Fifteen subjects will take 10 fish oil placebo capsules per day and 2 active vitamin C capsules per day for 3 weeks.

Group Type EXPERIMENTAL

Ascorbic Acid

Intervention Type DIETARY_SUPPLEMENT

2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks

Fish Oil Placebo

Intervention Type DIETARY_SUPPLEMENT

10 placebo fish oil (soy bean oil) capsules per day for 3 weeks

Active Fish Oil + Active Vitamin C

Following a 2-week washout period, all subjects from the other two arms (n=30) will take 10 active fish oil capsules per day and 2 active vitamin C capsules per day for 3 weeks.

Group Type EXPERIMENTAL

Fish Oil

Intervention Type DIETARY_SUPPLEMENT

10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks

Ascorbic Acid

Intervention Type DIETARY_SUPPLEMENT

2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fish Oil

10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks

Intervention Type DIETARY_SUPPLEMENT

Ascorbic Acid

2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks

Intervention Type DIETARY_SUPPLEMENT

Fish Oil Placebo

10 placebo fish oil (soy bean oil) capsules per day for 3 weeks

Intervention Type DIETARY_SUPPLEMENT

Ascorbic Acid Placebo

2 placebo ascorbic acid (sucrose) capsules per day for 3 weeks

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vitamin C Soy Bean Oil Table Sugar

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of asthma, based on medication use as well as history and symptoms as outlined in the NHLBI Guidelines for the Diagnosis and Management of Asthma
* Diagnosis of EIB, based on ≥10% fall in post-challenge FEV1, a measure of lung function, after dry air eucapnic voluntary hyperventilation (EVH), a simulated exercise challenge
* Not currently taking asthma maintenance medication or physician approval to discontinue current asthma medication for the duration of the study
* Not currently taking any fish oil or ascorbic acid supplements above the level recommended for adequate intake (if currently taking supplements, can participate if the subject stops taking the supplements for 2 weeks before starting the study and throughout the study)
* Agree to limit fish consumption to 1 fish meal per week throughout the study
* Agree to avoid vitamin C-rich foods throughout the study

Exclusion Criteria

* Resting FEV1 (the amount of air blown out in the first second of a forced exhalation) \<60% of predicted when off medication
* Pregnancy
* History of cardiovascular disease, including hyperlipidemia (high cholesterol) and hypertension (high blood pressure)
* History of bleeding disorders or delayed clotting time
* History of diabetes
* History of seizures
* Allergy to fish oil or ascorbic acid (vitamin C)
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indiana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Indiana University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Timothy D Mickleborough, PhD

Role: STUDY_DIRECTOR

Indiana University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Indiana University

Bloomington, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1181-9. doi: 10.1164/rccm.200303-373OC. Epub 2003 Aug 6.

Reference Type BACKGROUND
PMID: 12904324 (View on PubMed)

Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006 Jan;129(1):39-49. doi: 10.1378/chest.129.1.39.

Reference Type BACKGROUND
PMID: 16424411 (View on PubMed)

Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007 Aug;101(8):1770-8. doi: 10.1016/j.rmed.2007.02.014. Epub 2007 Apr 5.

Reference Type BACKGROUND
PMID: 17412579 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0910000751

Identifier Type: -

Identifier Source: org_study_id